Literature DB >> 17235731

Squamous cell carcinoma of the lung: pattern of epidermal growth factor receptor mutation distribution in different populations: a summary.

Viroj Wiwanitkit.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17235731     DOI： 10.1007/s00408-005-2595-7

Source DB:  PubMed          Journal:  Lung        ISSN： 0341-2040            Impact factor:   2.584


× No keyword cloud information.
  14 in total

Review 1.  Biomarkers in non-small cell lung cancer prevention.

Authors:  W Hilbe; S Dirnhofer; R Greil; E Wöll
Journal:  Eur J Cancer Prev       Date:  2004-10       Impact factor: 2.497

Review 2.  [Epidemiology, prognostic factors, staging, and treatment of non-small cell lung cancer].

Authors:  F André; W Jacot; J L Pujol; D Grunenwald; T Le Chevalier
Journal:  Bull Cancer       Date:  1999-10       Impact factor: 1.276

3.  EGFR mutations in non-small-cell lung cancer: analysis of a large series of cases and development of a rapid and sensitive method for diagnostic screening with potential implications on pharmacologic treatment.

Authors:  Antonio Marchetti; Carla Martella; Lara Felicioni; Fabio Barassi; Simona Salvatore; Antonio Chella; Pier P Camplese; Teodorico Iarussi; Felice Mucilli; Andrea Mezzetti; Franco Cuccurullo; Rocco Sacco; Fiamma Buttitta
Journal:  J Clin Oncol       Date:  2005-02-01       Impact factor: 44.544

4.  Identification of EGFR kinase domain mutations among lung cancer patients in China: implication for targeted cancer therapy.

Authors:  Bao Ming Qin; Xiao Chen; Jing De Zhu; Duan Qing Pei
Journal:  Cell Res       Date:  2005-03       Impact factor: 25.617

Review 5.  [Translational research on lung cancer--EGFR gene mutation].

Authors:  Takayuki Kosaka; Hideki Endoh; Yasushi Yatabe; Tetsuya Mitsudomi
Journal:  Gan To Kagaku Ryoho       Date:  2005-06

Review 6.  Lung cancer in India.

Authors:  D Behera; T Balamugesh
Journal:  Indian J Chest Dis Allied Sci       Date:  2004 Oct-Dec

7.  High frequency of epidermal growth factor receptor mutations with complex patterns in non-small cell lung cancers related to gefitinib responsiveness in Taiwan.

Authors:  Shiu-Feng Huang; Hui-Ping Liu; Ling-Hui Li; Yuan-Chieh Ku; Yu-Ning Fu; Hsien-Yu Tsai; Ya-Ting Chen; Yung-Feng Lin; Wen-Cheng Chang; Han-Pin Kuo; Yi-Cheng Wu; Yi-Rong Chen; Shih-Feng Tsai
Journal:  Clin Cancer Res       Date:  2004-12-15       Impact factor: 12.531

8.  Epidermal growth factor receptor (EGFR) downstream molecules as response predictive markers for gefitinib (Iressa, ZD1839) in chemotherapy-resistant non-small cell lung cancer.

Authors:  Sae-Won Han; Pil Gyu Hwang; Doo Hyun Chung; Dong-Wan Kim; Seock-Ah Im; Young Tae Kim; Tae-You Kim; Dae Seog Heo; Yung-Jue Bang; Noe Kyeong Kim
Journal:  Int J Cancer       Date:  2005-01-01       Impact factor: 7.396

Review 9.  Chemoprevention of lung cancer--from biology to clinical reality.

Authors:  R C Winterhalder; F R Hirsch; G K Kotantoulas; W A Franklin; P A Bunn
Journal:  Ann Oncol       Date:  2004-02       Impact factor: 32.976

Review 10.  Chemoprevention of lung cancer.

Authors:  Jean-Charles Soria; Edward S Kim; Jérôme Fayette; Sylvie Lantuejoul; Eric Deutsch; Waun Ki Hong
Journal:  Lancet Oncol       Date:  2003-11       Impact factor: 41.316
View more
  1 in total

Review 1.  Refining the treatment of advanced nonsmall cell lung cancer.

Authors:  Shin Ogita; Antoinette J Wozniak
Journal:  Lung Cancer (Auckl)       Date:  2010-05-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.